Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Mary

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Inflammatory Bowel Diseases|May 3, 2014
Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's diseaseSylvie Rajca, Virginie Grondin, Edouard Louis, et al.
Gastroenterology|July 30, 2013
Reliability and initial validation of the ulcerative colitis endoscopic index of severitySimon P L Travis, Dan Schnell, Piotr Krzeski, et al.
Gut|October 15, 2011
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)Simon P L Travis, Dan Schnell, Piotr Krzeski, et al.
Blood|November 4, 2009
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM)Murielle Roussel, Philippe Moreau, Anne Huynh, et al.
Journal of Crohn'S & Colitis|June 13, 2025
A Randomized Controlled Trial Of Antibiotics Targeting Adherent And Invasive Escherichia Coli (Aiec) Vs Placebo In Crohn's Disease: The Teorem TrialFranck Carbonnel, Nicolas Barnich, Patricia Lepage, et al.
Gut|January 26, 2017
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) studyYoram Bouhnik, Franck Carbonnel, David Laharie, et al.
Gastroenterology|May 30, 2021
Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's DiseaseBenjamin Pariente, Joana Torres, Johan Burisch, et al.
The New England Journal of Medicine|June 3, 2025
Measurable Residual Disease-Guided Therapy in Newly Diagnosed MyelomaAurore Perrot, Jérôme Lambert, Cyrille Hulin, et al.
Lancet (London, England)|October 9, 2007
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trialThierry Facon, Jean Yves Mary, Cyrille Hulin, et al.
Therapeutic Advances in Gastroenterology|September 2, 2025
The CROCO (CROhn's Disease COhort Study) - study design and protocolJoana Revés, Anthony Buisson, Johan Burisch, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Inflammatory Bowel Diseases|May 3, 2014
Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's diseaseSylvie Rajca, Virginie Grondin, Edouard Louis, et al.
Gastroenterology|July 30, 2013
Reliability and initial validation of the ulcerative colitis endoscopic index of severitySimon P L Travis, Dan Schnell, Piotr Krzeski, et al.
Gut|October 15, 2011
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)Simon P L Travis, Dan Schnell, Piotr Krzeski, et al.
Blood|November 4, 2009
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM)Murielle Roussel, Philippe Moreau, Anne Huynh, et al.
Journal of Crohn'S & Colitis|June 13, 2025
A Randomized Controlled Trial Of Antibiotics Targeting Adherent And Invasive Escherichia Coli (Aiec) Vs Placebo In Crohn's Disease: The Teorem TrialFranck Carbonnel, Nicolas Barnich, Patricia Lepage, et al.
Gut|January 26, 2017
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) studyYoram Bouhnik, Franck Carbonnel, David Laharie, et al.
Gastroenterology|May 30, 2021
Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's DiseaseBenjamin Pariente, Joana Torres, Johan Burisch, et al.
The New England Journal of Medicine|June 3, 2025
Measurable Residual Disease-Guided Therapy in Newly Diagnosed MyelomaAurore Perrot, Jérôme Lambert, Cyrille Hulin, et al.
Lancet (London, England)|October 9, 2007
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trialThierry Facon, Jean Yves Mary, Cyrille Hulin, et al.
Therapeutic Advances in Gastroenterology|September 2, 2025
The CROCO (CROhn's Disease COhort Study) - study design and protocolJoana Revés, Anthony Buisson, Johan Burisch, et al.
Pageof 11